Chart has a huge bullish candle today (what doesnt on a 900+ point upward move from the dow )

Resistance at 2.32 and 2.81 ahead with support at 1.40 we must hold over imo

__________________
All my posts are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here

Finally it looks like ARIA Ariad Pharmaceuticals Inc. has started to form a bottom, a break of 1.40 would be key here.

__________________
All my posts are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here

Ariad Pharmaceuticals Inc. - ARIA A perfect swing trade lately from about 1.15 to 1.30 or so, still a break of 1.40 could get the stock started upward more.

__________________
All my posts are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here

ARIAD Pharmaceuticals Inc. (ARIA)
Sector Healthcare - Industry Biotechnology - Exchange NAS

Short Interest (Shares Short) 5,329,700
Days To Cover (Short Interest Ratio) 16.1
Short Percent of Float 8.73 %
Short Interest - Prior 5,445,900
Short % Increase / Decrease -2.13 %
Short Squeeze Ranking™ -102

% From 52-Wk High ($ 4.56 ) -242.86 %
% From 52-Wk Low ($ 1.09 ) 18.05 %
% From 200-Day MA ($ 2.36 ) -77.44 %
% From 50-Day MA ($ 1.52 ) -14.29 %
Price % Change (52-Week) -72.50 %

Shares Float 61,020,000
Total Shares Outstanding 69,476,467
% Owned by Insiders 3.93 %
% Owned by Institutions 56.80 %
Market Cap. $ 92,403,701
Trading Volume - Today 912,395
Trading Volume - Average 331,200
Trading Volume - Today vs. Average 275.48 %
Earnings Per Share -0.89
PE Ratio
Record Date 2008-DecA

Dividend -
Employees 116
Optionable Yes
Shortable No
Beta 1,50
Volatility 15.13% 14.48%
Perf Week 3.10%
Perf Month -4.32%
Perf Quarter -53.50%
Perf Half Y -49.04%
Perf Year -69.91%
Perf YTD -68.71%

Target Price from Analyst Recommendation :
16-Oct-08 Initiated Merriman Curhan Ford Neutral
02-Jun-08 Reiterated Canaccord Adams Hold $5.20 → $3.50
14-Dec-07 Initiated Jefferies & Co Buy $8
28-Nov-07 Downgrade JP Morgan Overweight → Neutral
13-Jul-07 Downgrade Canaccord Adams Buy → Hold $6
12-Jul-07 Reiterated Lazard Capital Buy $9 → $11
09-Apr-07 Reiterated Lehman Brothers Overweight $16 → $7
16-Feb-07 Reiterated Lazard Capital Buy $11 → $9
12-Feb-07 Upgrade JP Morgan Neutral → Overweight

Summary
ARIAD Pharmaceuticals, Inc. is engaged in the discovery and development of medicines to treat cancers by regulating cell signaling with small molecules. The Company is developing an approach to patients with cancer that addresses aggressive and advanced-stage cancers. Its lead cancer product candidate, deforolimus (previously known as AP23573), is an internally discovered, potent inhibitor of the protein mTOR. Deforolimus was discovered in a research and development program conducted on behalf of ARIAD Gene Therapeutics, Inc., an 80%-owned subsidiary. AP24534, the second product candidate, is a multi-targeted kinase inhibitor believed to have potential applications in cancer, including various forms of leukemia. ARIAD Pharmaceuticals also has a focused drug discovery program centered on small-molecule therapies, molecularly targeted to cell-signaling pathways implicated in cancer.

Adress
26 Landsdowne Street
Cambridge, MA 02139
United States - Map
+1-617-4940400 (Phone)
+1-617-4948144 (Fax)
Company website:
Leading the Pathway to Better Cancer Therapies - ARIAD

Looking for a specific market listing? Select from the list below:
Symbol Company Name Prime Exchange
Symbol Company Name Prime Exchange
ARIA.W Ariad Pharmaceuticals Inc NASD ADF
ARIA.OQ Ariad Pharmaceuticals Inc NASDAQ Stock Exchange Global Market
ARIA.DE Ariad Pharmaceuticals Inc Xetra
ARIA.O Ariad Pharmaceuticals Inc Consolidated Issue listed on NASDAQ Global Market
ARIA.DF Ariad Pharmaceuticals Inc NASD ADF
ARIA.BE Ariad Pharmaceuticals Inc Berlin Stock Exchange
ARIA.F Ariad Pharmaceuticals Inc Frankfurt Stock Exchange
ARIA.C Ariad Pharmaceuticals Inc Cincinatti Stock Exchange
ARIA.P Ariad Pharmaceuticals Inc NYSE Arca
ARIA.MU Ariad Pharmaceuticals Inc Munich Stock Exchange
ARIA.D Ariad Pharmaceuticals Inc Dusseldorf Stock Exchange
ARIA.PH Ariad Pharmaceuticals Inc Philadelphia Stock Exchange
ARIA.MW Ariad Pharmaceuticals Inc Midwest Stock Exchange

I thought this stock had hit the bottom. Looks like it fell again. What is going on with this thing?

I wanna see this one back in at least the $2 range.

After the FEDs cut the interest rated we spiked back to the daily high. still, i'd like to see this one back up in the $2 range.

Amyone got anything on this stock?

back over 1.20. volume is starting to pick up, looking good.